Australia's most trusted
source of pharma news
Tuesday, 31 March 2026
Posted 31 March 2026 AM
Internal and external pressures on the Federal Government could see the 'stars align' to drive greater uptake of biosimiliar medicines in Australia, according to Sandoz Head of Medical Affairs and Policy, Chad Rieger.
The Sandoz Biosimilars Policy Summit is being held at Parliament House, Canberra today, bringing together key stakeholders including patient advocates, clinicians, pharmacists, industry and government, to discuss policy access barriers and create a path forward.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.